Ikaros 7 offers a fully automated, DNN-based workflow that generates preliminary karyogram drafts in the background. Users receive clearly labeled draft karyograms and band count estimates alongside metaphase images; these are only added to official case data and reports after explicit user approval.

Designed for clarity and flexibility, Ikaros 7 enhances visualization of even subtle fluorescence signals, enabling precise analysis. Integrated workflows streamline complex tasks, reduce manual steps, and ensure a smooth imaging process from acquisition to evaluation.

Ikaros 7.0 is classified in the European Union as in vitro diagnostic Software as a Medical Device (SaMD) Class A under IVDR (EU) 2017/746 and carries the CE mark unless otherwise specified. MetaSystems products are used worldwide and should be operated in accordance with their intended use and applicable regional regulations.